Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. The company said patients who took 1,000 milligrams of LX1031 four times per day had significantly less pain and discomfort from... Irritable bowel syndrome - Clinical trial - Health - Lexicon Pharmaceuticals - Conditions and DiseasesView the full article
Yahoo- Lexicon says IBS drug met mid-stage study goal (San Francisco Chronicle)
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!
